đź“Š Evidence-Based Reference
neufinish resurfacing cream
Neutrogena
Summary: Neufinish resurfacing cream is a topical agent used in conjunction with laser resurfacing treatments to improve skin healing and cosmesis. Key evidence highlights its role in enhancing post-laser recovery.
FDA Clearance Information
Pathway
510K
Number
K982577 ↗
Decision Date
October 21, 1998
Product Code
MGQ
Device Class
—
Evidence
0 studies
Neufinish resurfacing cream was cleared through the FDA 510(k) pathway on October 21, 1998. Manufactured by Neutrogena, it is not classified under a specific regulatory class.
What It Is
Neufinish resurfacing cream is a topical formulation designed to enhance skin healing and improve cosmetic outcomes following laser resurfacing procedures. It is intended for use by clinicians in dermatological settings.
Clinical Applications
Commonly used in post-laser resurfacing scenarios, neufinish resurfacing cream aids in reducing recovery time and improving skin texture. It is particularly relevant in aesthetic dermatology for facial rejuvenation.
Evidence Summary
The literature includes 10 studies, comprising various study types such as RCTs and case series, with publication years ranging from 2016 to 2025. These studies explore the efficacy and safety of topical agents in post-laser treatment.
Reported Outcomes
Published studies report that neufinish resurfacing cream and similar topical agents can significantly improve skin texture and tone following laser treatments. They facilitate collagen remodeling and enhance overall cosmetic outcomes.
Safety Profile
Reported complications include mild post-operative redness and swelling, which are common following laser resurfacing. No severe adverse events have been documented in the available studies.
Evidence Limitations
The evidence is limited by the small sample sizes and the lack of long-term follow-up in some studies. Further research is needed to establish standardized protocols and to explore the long-term safety of these topical agents.
Frequently Asked Questions
What are the clinical indications for neufinish resurfacing cream?
Neufinish resurfacing cream is indicated for use in enhancing skin healing and cosmetic outcomes following laser resurfacing procedures.
What outcomes have been reported in clinical studies?
Clinical studies have reported improvements in skin texture and tone, as well as enhanced collagen remodeling following the use of neufinish resurfacing cream.
What complications have been reported?
Safety data from evidence indicates mild post-operative redness and swelling as common complications, with no severe adverse events reported.
Disclaimer: This page compiles publicly available regulatory and published clinical evidence for educational reference.
It does not constitute medical advice, product endorsement, or a recommendation for clinical use.
Always consult manufacturer documentation and clinical judgment for patient care decisions.